Impact of methicillin resistance on mortality in Staphylococcus aureus endocarditis: a systematic review and

Durga Shankar Meena1, Deepak Kumar2, Gopal Krishana Bohra2

  • 1Division of Infectious Diseases (Department of General Medicine), All India Institute of Medical Sciences, Jodhpur, India. dsmims14@gmail.com.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) endocarditis leads to higher short-term mortality compared to methicillin-susceptible S. aureus (MSSA). Major complications were similar between MRSA and MSSA endocarditis patients.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Public Health

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of infective endocarditis.
  • Outcomes for MRSA endocarditis are often poor, but comparative mortality risk versus MSSA is unclear.

Purpose of the Study:

  • To quantify and assess the consistency of the mortality risk associated with MRSA endocarditis compared to MSSA endocarditis.

Main Methods:

  • Systematic review and meta-analysis of studies from PubMed, Embase, Scopus, and Cochrane Library up to November 2025.
  • Random-effects model used to calculate pooled risk ratios (RRs) for mortality.
  • Heterogeneity and publication bias assessed via stratified analyses, meta-regression, funnel plots, and Egger's test.

Main Results:

  • Twenty-four studies including 3291 patients (1011 MRSA, 2280 MSSA) were analyzed.
  • MRSA endocarditis showed significantly higher short-term mortality (30.9% vs 25.6%; RR 1.48).
  • Mortality remained higher in MRSA cases across various subgroup analyses; complications like heart failure, embolic events, stroke, and surgery rates were comparable.

Conclusions:

  • MRSA endocarditis is associated with substantially higher short-term mortality than MSSA endocarditis.
  • This increased mortality risk is consistent across different study designs and patient characteristics.
  • Key complications of endocarditis do not significantly differ between MRSA and MSSA infections.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...